dbACP: A Comprehensive Database of Anti-Cancer Peptides

30 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp01251 Aurein 3.1 GLFDIVKKIAGHIAGSI Southern bell frog, Australia Cell membrane disruption Not specified Breast tumor cell line Breast cancer LC50 : 10-100 µM
dbacp01252 Aurein 3.1 GLFDIVKKIAGHIAGSI Southern bell frog, Australia Cell membrane disruption Not specified Leukemia tumor cell line Leukemia cancer LC50 : 10 µM
dbacp01253 Aurein 3.1 GLFDIVKKIAGHIAGSI Southern bell frog, Australia Cell membrane disruption Not specified Lung tumor cell line Lung cancer LC50 : 10 µM
dbacp01254 Aurein 3.1 GLFDIVKKIAGHIAGSI Southern bell frog, Australia Cell membrane disruption Not specified Colon tumor cell line Colon cancer LC50 : 10 µM
dbacp01255 Aurein 3.1 GLFDIVKKIAGHIAGSI Southern bell frog, Australia Cell membrane disruption Not specified Brain tumor cell line Brain tumor LC50 : 10-100 µM
dbacp01256 Aurein 3.1 GLFDIVKKIAGHIAGSI Southern bell frog, Australia Cell membrane disruption Not specified Skin tumor cell line Skin cancer LC50 : 10-100 µM
dbacp01257 Aurein 3.1 GLFDIVKKIAGHIAGSI Southern bell frog, Australia Cell membrane disruption Not specified Ovary tumor cell line Ovarian cancer LC50 : 10-100 µM
dbacp01258 Aurein 3.1 GLFDIVKKIAGHIAGSI Southern bell frog, Australia Cell membrane disruption Not specified Renal tumor cell line Renal cancer LC50 : 10-100 µM
dbacp01259 Aurein 3.1 GLFDIVKKIAGHIAGSI Southern bell frog, Australia Cell membrane disruption Not specified Prostate tumor cell line Prostate cancer LC50 : 10 µM
dbacp01260 Aurein 3.1 GLFDIVKKIAGHIAGSI Southern bell frog, Australia Cell membrane disruption Not specified Breast tumor cell line Breast cancer LC50 : 10-100 µM
dbacp01261 Aurein 3.1 GLFDIVKKIAGHIAGSI Southern bell frog, Australia Cell membrane disruption Not specified Leukemia tumor cell line Leukemia cancer LC50 : 10 µM
dbacp01262 Aurein 3.1 GLFDIVKKIAGHIAGSI Southern bell frog, Australia Cell membrane disruption Not specified Lung tumor cell line Lung cancer LC50 : 10 µM
dbacp01263 Aurein 3.1 GLFDIVKKIAGHIAGSI Southern bell frog, Australia Cell membrane disruption Not specified Colon tumor cell line Colon cancer LC50 : 10 µM
dbacp01264 Aurein 3.1 GLFDIVKKIAGHIAGSI Southern bell frog, Australia Cell membrane disruption Not specified Brain tumor cell line Brain tumor LC50 : 10-100 µM
dbacp01265 Aurein 3.1 GLFDIVKKIAGHIAGSI Southern bell frog, Australia Cell membrane disruption Not specified Skin tumor cell line Skin cancer LC50 : 10-100 µM
dbacp01266 Aurein 3.1 GLFDIVKKIAGHIAGSI Southern bell frog, Australia Cell membrane disruption Not specified Ovary tumor cell line Ovarian cancer LC50 : 10-100 µM
dbacp01267 Aurein 3.1 GLFDIVKKIAGHIAGSI Southern bell frog, Australia Cell membrane disruption Not specified Renal tumor cell line Renal cancer LC50 : 10-100 µM
dbacp01268 Aurein 3.1 GLFDIVKKIAGHIAGSI Southern bell frog, Australia Cell membrane disruption Not specified Prostate tumor cell line Prostate cancer LC50 : 10 µM
dbacp01269 Aurein 3.1 GLFDIVKKIAGHIAGSI Southern bell frog, Australia Cell membrane disruption Not specified Not specified Not specified LC50 : 10⁻⁵ to 10⁻⁴ M
dbacp01357 Aurein-3.1 GLFDIVKKIAGHIAGSI Southern bell frog; also golden bell frog Not specified Not specified Not found Not found Not found
dbacp01358 Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] GLFDIVKKIAGHIAGSI Southern bell frog Cell membrane disintegration One-dose and five-dose assay CCRF-CEM Leukemia IC50 : 4-5 μM
dbacp01359 Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] GLFDIVKKIAGHIAGSI Southern bell frog Cell membrane disintegration One-dose and five-dose assay NCI-H23 Lung cancer IC50 : 5 μM
dbacp01360 Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] GLFDIVKKIAGHIAGSI Southern bell frog Cell membrane disintegration One-dose and five-dose assay COLO 205 Colon cancer IC50 : 4-5 μM
dbacp01361 Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] GLFDIVKKIAGHIAGSI Southern bell frog Cell membrane disintegration One-dose and five-dose assay U251 CNS cancer IC50 : 5 μM
dbacp01362 Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] GLFDIVKKIAGHIAGSI Southern bell frog Cell membrane disintegration One-dose and five-dose assay LOX IMVI Melanoma IC50 : 5 μM
dbacp01363 Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] GLFDIVKKIAGHIAGSI Southern bell frog Cell membrane disintegration One-dose and five-dose assay NCI/ADR-RES Ovarian cancer IC50 : 5 μM
dbacp01364 Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] GLFDIVKKIAGHIAGSI Southern bell frog Cell membrane disintegration One-dose and five-dose assay 786-0 Renal cancer IC50 : 5 μM
dbacp01365 Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] GLFDIVKKIAGHIAGSI Southern bell frog Cell membrane disintegration One-dose and five-dose assay Not found Prostate cancer IC50 : 5 μM
dbacp01366 Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] GLFDIVKKIAGHIAGSI Southern bell frog Cell membrane disintegration One-dose and five-dose assay BT-549 Breast cancer IC50 : 5 μM
dbacp01368 Aurein-3.1 [Cleaved into: Aurein-3.1.1; Aurein-3.1.2] GLFDIVKKIAGHIAGSI Southern bell frog Cell membrane disintegration Not specified Not specified Not specified LC50 : 10⁻⁵ - 10⁻⁴ M